[Skip to Navigation]
Views 2,731
Citations 0
JAMA Insights
Women's Health
July 27, 2021

Anabolic Therapy for Osteoporosis

Author Affiliations
  • 1Division of Epidemiology & Community Health, Department of Medicine, University of Minnesota, Minneapolis
  • 2Center for Care Delivery & Outcomes Research, VA Health Care System, Minneapolis
  • 3HealthPartners Institute, Bloomington, Minnesota
  • 4Division of Health Policy & Management, University of Minnesota, Minneapolis
JAMA. 2021;326(4):350-351. doi:10.1001/jama.2021.0233

Medications used to reduce the risk of osteoporosis-related fractures are classified as antiresorptive agents (that suppress osteoclast-mediated bone resorption) or anabolic therapies (that promote new bone formation by activating osteoblasts). Antiresorptive medications have already been reviewed.1 This JAMA Insights discusses the use of anabolic medications, including teriparatide, abaloparatide, and romosozumab.